Labs / Assays & in vitro testing

GlyProVac ApS
Odense, Denmark · glyprovac.com
On your own
Free. Their own email.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
GlyProVac ApS develops pre-clinical bacterial subunit vaccine candidates using its proprietary BEMAP technology. The company focuses on vaccines against bacterial infections linked to antimicrobial resistance, with work centered on E. coli and urinary tract infections.
They take quote requests by email.
What they offer
Bacterial vaccine discovery platform
Develops novel bacterial subunit vaccine candidates based on the proprietary BEMAP platform.
BEMAP sample enrichment for O-linked glycosylation
Uses a mass spectrometry-based enrichment method to identify O-linked protein glycosylations.
Antigen discovery for bacterial pathogens
Identifies glycosylated bacterial protein targets relevant to pathogenesis and vaccine development.
What they work on
- Modalities
- Peptide, Vaccine
- Species and models
- E. coli, Pseudomonas aeruginosa, Shigella, Enterotoxigenic Escherichia coli (ETEC)
- Assays and studies
- mass spectrometry, sample enrichment, O-linked glycosylation identification
- Instruments and platforms
- titanium dioxide
- Therapeutic areas
- antimicrobial resistance, urinary tract infections, bacterial infections
- Founded
- 2007
Similar labs. Aurigene Pharmaceutical Services, Bioneeds, Creative Biolabs, Devsynthesis
Found in a contract services directory. Listing built from glyprovac.com. Work here? Claim this listing.